Skip to main content
. 2021 Jan 4;13(1):e12486. doi: 10.7759/cureus.12486

Table 5. Antibiotics: resistance pattern for gram-negative organisms.

Antibiotics    
Citrobacter diversus (n=7) E. coli (n=81) Enterobacter (n=1) Klebsiella (n=18) Nonfermenting gram-negative bacilli (n=3) Proteus mirabilus (n=1) Pseudomonas (n=10) Serratia marscesans (n=2)  
Amikacin 1(14.3%) 6(7.4%) 1(100%) 4(22.2%) 0(0%) 0(0%) 2(20%) 0(0%)  
Gentamicin 5(71.4%) 24(29.6%) 1(100%) 4(22.2%) 0(0%) 0(0%) 3(30%) 0(0%)  
Amoxicillin-clavulanic acid 6(85.7%) 58(71.6%) 1(100%) 13(72.2%) 2(66.7%) 1(100%) NA 1(50%)  
Aztreonam 4(57.1%) 63(77.8%) 1(100%) 11(61.1%) 0(0%) 1(100%) 1(10%) 0(0%)  
Cefotaxime 5(71.4%) 63(77.8%) 1(100%) 11(61.1%) 1(33.3%) 1(100%) NA 0(0%)  
Ceftazidime 4(57.1%) 63(77.8%) 1(100%) 11(61.1%) 0(0%) 1(100%) 1(10%) 0(0%)  
Ciprofloxacin 3(42.9%) 69(85.2%) 0(0%) 11(61.1%) 0(0%) 1(100%) 4(40%) 1(50%)  
Norfloxacin 2(28.6%) 70(86.4%) 0(0%) 9(50%) 0(0%) 1(100%) 2(20%) 0(0%)  
Levofloxacin 1(14.3%) 63(77.8%) 0(0%) 9(50%) 0(0%) 1(100%) 1(10%) 0(0%)  
Nitrofurantoin 5(71.4%) 16(19.8%) 0(0%) 13(72.2%) 1(33.3%) 0(0%) NA 2(100%)  
Ertapenem 1(14.3%) 11(13.6%) 0(0%) 4(22.2%) 0(0%) 0(0%) NA 0(0%)  
Imipenem 0(0%) 4(4.9%) 0(0%) 3(16.7%) 0(0%) 0(0%) 0(0%) 0(0%)  
Meropenem 0(0%) 2(2.5%) 0(0%) 4(22.2%) 0(0%) 0(0%) 0(0%) 0(0%)  
Cefoperazone -sulbactam 0(0%) 12(14.8%) 0(0%) 4(22.2%) 0(0%) 0(0%) 1(10%) 0(0%)  
Piperacillin-tazobactam 0(0%) 13(16%) 0(0%) 4(22.2%) 0(0%) 0(0%) 0(0%) 0(0%)  
Polymyxin-B 0(0%) 1(1.2%) 0(0%) 0(0%) 0(0%) 0(0%) 0(0%) 0(0%)  
Colistin 0(0%) 1(1.2%) 0(0%) 0(0%) 0(0%) 0(0%) 1(10%) 0(0%)  
Tigecycline 0(0%) 1(1.2%) 0(0%) 0(0%) 0(0%) 0(0%) NA 0(0%)  
Fosfomycin 0(0%) 0(0%) 0(0%) 0(0%) 1(33.3%) 0(0%) NA 0(0%)  
Doxycycline 3(42.9%) 30(37%) 0(0%) 4(22.2%) 2(66.7%) 0(0%) NA 0(0%)  
Cotrimoxazole 5(71.4%) 43(53.1%) 1(100%) 10(55.6%) 1(33.3%) 1(100%) NA 0(0%)